Foreign Manufacturing Cost-Savings Might Be Offset By Regulatory Due Diligence, FDA's Woodcock Cautions

Companies may have more work down the line dealing with regulatory authorities if they manufacture products in foreign countries not following an accepted regulatory structure.

More from Archive

More from Pink Sheet